Chimeric Therapeutics Ltd
ASX:CHM
Chimeric Therapeutics Ltd
ASX:CHM
Price:
0.002
AUD
Market Closed
Market Cap:
AU$7.3m
Relative Value
The Relative Value of one
CHM
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.002 AUD,
Chimeric Therapeutics Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CHM Relative Value
HIDDEN
Multiples Across Competitors
CHM Competitors Multiples
Chimeric Therapeutics Ltd Competitors
Chimeric Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Chimeric Therapeutics Ltd
ASX:CHM
|
7.3m AUD | 1.8 | -0.7 | -0.7 | -0.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
383.2B USD | 6.4 | 163.2 | 15.9 | 22.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.2B USD | 5.5 | 28.2 | 19.9 | 19.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.9B USD | 6.2 | 22.4 | 15.2 | 15.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.9B USD | 10.2 | 32.7 | 24 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD | 5.7 | 18.1 | 15.4 | 17.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.9B AUD | 3.9 | 20.4 | 13.6 | 17 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR | 14.5 | 34 | 58.1 | 59.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
